Clinician-Guided TRT & Andropause Optimization

Precision Male Hormone Restoration, Metabolic Longevity & Peak Performance | Manasquan & Wall, NJ

Male endocrine vitality declines predictably after age 30, with bioavailable testosterone dropping by roughly 1% to 2% annually. At Mirelle Institute, male hormone optimization is approached not through commercial, one-size-fits-all subscription mills, but through rigorous clinical medicine governed by Dr. Corina Ianculovici (DNP, FAAMFRM, ABAARM).
We evaluate testosterone as a primary metabolic and neuroendocrine signaling hormone essential for cardiovascular endurance, visceral fat regulation, lean muscle architecture, bone mineral density, and cognitive stamina. Through extensive biomarker mapping and customized bio-identical protocols, we safely restore physiological androgen balance while safeguarding long-term systemic health.

Clinical Indications: Identifying Andropause: Beyond Simple "Low T"

 Andropause (hypogonadism) manifests through a constellation of systemic symptoms often dismissed as ordinary aging. Clinical candidates for optimization frequently present with:

Metabolic & Body Composition Shifts: Sarcopenia (loss of skeletal muscle mass), persistent visceral abdominal adiposity, and resistance to diet and resistance training.


Cognitive & Energy Depletion: Mid-afternoon energy crashes, reduced executive drive, poor focus, and disrupted non-REM restorative sleep patterns.


Vascular & Intimate Function: Decreased libido, reduced spontaneous nocturnal erections, diminished sexual stamina, and attenuated recovery.


Systemic Resilience: Prolonged post-workout recovery times, elevated systemic inflammation, and sub-optimal cardiovascular lipid parameters.



The Mirelle Diagnostic Difference: Advanced Multi-Analyte Mapping


The Telehealth Subscription Pitfall: Why Precision Medicine Demands More Than a Questionnaire

The rise of direct-to-consumer virtual TRT platforms has turned hormone therapy into a mail-order convenience. While telehealth offers accessibility, many algorithmic subscription models pose serious long-term physiological hazards by cutting critical clinical corners:
  • Superficial Lab Panels: Virtual mills often test only morning Total Testosterone, ignoring Sex Hormone-Binding Globulin (SHBG), free testosterone fractions, sensitive estradiol, and pituitary signaling (LH/FSH).


  • Unmonitored Polycythemia & Cardiovascular Strain: Exogenous testosterone stimulates red blood cell production. Without rigorous, routine blood monitoring of hematocrit and hemoglobin, elevated blood viscosity can significantly elevate the risk of hypertension, vascular strain, and thromboembolic events.


  • Cookie-Cutter Megadosing: Handing every patient a fixed weekly dose of 200 mg cypionate frequently leads to excessive aromatization into estrogen, fluid retention, mood volatility, accelerated testicular atrophy, and hair follicle compromise.


  • No In-Person Structural or Pelvic Integration: A subscription vial delivered in the mail cannot treat pelvic floor tension, microvascular endothelial dysfunction, or soft-tissue fibrotic remodeling.


Standard clinics often rely solely on a single morning Total Testosterone level. Because testosterone binds tightly to Sex Hormone-Binding Globulin (SHBG) and albumin, Total Testosterone fails to show what is biologically active at the cellular receptor level.

At Mirelle Institute, Dr. Corina Ianculovici treats testosterone therapy as a foundational metabolic discipline governed by continuous biomarker surveillance, organ-protective protocols, and true clinical oversight.

Our comprehensive diagnostic panel evaluates:
  • Free & Bioavailable Testosterone: Measuring the unbound hormone actively signaling cellular receptors.
  • SHBG & Albumin Dynamics: Assessing transport proteins influenced by metabolic insulin resistance and hepatic health.
  • Estradiol Balance (Sensitive LC/MS): Regulating aromatization to prevent gynecomastia, fluid retention, or mood swings while maintaining vital bone and cardiovascular protection.
  • LH & FSH Signaling: Determining primary testicular hypogonadism versus secondary pituitary axis suppression.
  • Cardiovascular, Renal & Hematologic Safety: Baseline and serial monitoring of Complete Blood Count (Hematocrit/Hemoglobin), Comprehensive Metabolic Panel, lipid fractions, and Total/Free PSA.



Individualized Protocols & Longevity Synergies

Every protocol is tailored to individual biomarker profiles, lifestyle demands, and fertility preservation priorities:
  • Custom Compounded Formulations: Precision micro-dosed subcutaneous or intramuscular therapies and customized bio-identical transdermal matrices formulated without artificial dyes or systemic irritants.
  • Testicular Axis & Fertility Support: Adjunctive protocols utilizing hCG or enclomiphene to sustain endogenous LH signaling, intratesticular testosterone production, and spermatogenesis where indicated.
  • Intimate Restoration Multi-Modalities: For men experiencing vascular or pelvic floor compromises alongside hormonal decline, TRT integrates seamlessly with The P-Shot® (autologous PRFM via the Magellan® TruPRP double-spin system), BOCOX® Vascular Neuromodulation, and BTL EMSELLA® HIFEM® Pelvic Core Conditioning.
  • Metabolic Synergy: Coordinated with The Metabolic Code® and Elite Medical Weight Loss to resolve insulin resistance and optimize lean tissue partitioning.
Schedule a Clinical TRT Consultation